Development and external validation of a machine learning-based Cox model for predicting in-hospital survival in

Donglin Li1, Xinyi He2, Yanlin Zhou3

  • 1Department of Thoracic Surgery, Suining Central Hospital, Suining, 629000, China.

Scientific Reports
|May 25, 2026
PubMed

Insights

Machine learning accurately predicts survival in classical heatstroke (CHS) patients. This prognostic tool aids clinical decisions and intelligent monitoring for critical care.

Area of Science:

  • Critical Care Medicine
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Classical heatstroke (CHS) is a critical medical emergency requiring precise prognostic evaluation.
  • Existing prognostic tools for CHS are limited, highlighting the need for advanced predictive methods.
  • Machine learning (ML) applications for predicting clinical outcomes in CHS are underexplored.

Purpose of the Study:

  • To develop and externally validate a machine learning-based Cox model for predicting survival in hospitalized CHS patients.
  • To identify robust prognostic features for CHS using an innovative ML framework.
  • To create a visual prognostic tool (nomogram) for clinical use.

Main Methods:

  • A retrospective multicenter study involving 538 CHS patients from eight hospitals in western China.
  • Utilized an ML framework with nine algorithms and 54 combinations to identify predictors.
  • Developed a multivariable Cox regression model incorporating significant predictors, visualized as a nomogram.

Main Results:

  • The Lasso + SuperPC ML combination achieved high predictive accuracy (C-indexes: 0.921 training, 0.811 validation).
  • The developed nomogram demonstrated strong performance in predicting 10-, 20-, and 30-day survival across cohorts (AUCs ranging from 0.710 to 0.91).
  • Calibration curves and Kaplan-Meier analyses confirmed the model's accuracy and ability to stratify patient risk effectively.

Conclusions:

  • An accurate ML-integrated prognostic tool for hospitalized CHS patients was successfully developed and validated.
  • This tool supports personalized clinical decision-making and enhances intelligent prognosis monitoring in critical care settings.
  • The study opens new avenues for leveraging ML in critical care prognosis.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of interest.